VIMTA LABS
|
The Current P/E Ratio of VIMTA LABS is 38.20.
Share Price | ₹1,018.0 | May 13,2025 |
Market Cap | ₹2,259.8 Cr | |
Earnings-TTM | ₹59.2 Cr | TTM-Consolidated Results |
Price/Earnings | 38.20x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VIMTA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,259.8 Cr] as on May 13,2025
(/) Earnings [ ₹59.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.20x ]
Thus, for VIMTA LABS , the investors are currently willing to pay 38.20 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VIMTA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VIMTA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of VIMTA LABS
PE Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.22x.
- VIMTA LABS 's operated at median p/e ratio of 16.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 24.04x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2023 of 14.44x.
How does VIMTA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VIMTA LABS | 59.16 | 38.20 | 2,259.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.52 | 407,971.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 77.96 | 161,153.0 |
CIPLA LTD | 5,291.05 | 23.19 | 122,717.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.75 | 109,392.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 17.66 | 100,702.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.26 | 105,125.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.76 | 90,727.1 |
LUPIN LTD | 2,892.10 | 32.57 | 94,200.0 |
AUROBINDO PHARMA LTD | 3,500.25 | 20.28 | 70,997.2 |
ABBOTT INDIA LTD | 1,334.46 | 48.45 | 64,648.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VIMTA LABS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.66x |
Max industry PE | 77.96x |
Median industry PE | 35.52x |
Average industry PE | 38.51x |
You may also like the below Video Courses